When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TCON - Tracon Pharma to commence pivotal study of lead drug in H2
TRACON Pharmaceuticals Inc.
TRACON Pharmaceuticals (NASDAQ:TCON) is on go with a pivotal trial, ENVASARC, evaluating lead drug envafolimab in soft tissue sarcoma subtypes of undifferentiated pleomorphic sarcoma and myxofibrosarcoma after meeting with the FDA to clarify the key elements of the study.
More news on: TRACON Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,